Home > Financial Ratios > GLAND PHARMA
AD     Remove this Ad

GLAND PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.950.640.600.400.40

What is the latest Fixed Capital/Sales ratio of GLAND PHARMA ?

The latest Fixed Capital/Sales ratio of GLAND PHARMA is 0.95 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.95
Mar20240.64
Mar20230.60
Mar20220.40
Mar20210.40

How is Fixed Capital/Sales of GLAND PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.95
48.44
Mar2024 0.64
6.67
Mar2023 0.6
50.00
Mar2022 0.4
0.00
Mar2021 0.4 -

Other Financial Ratios of GLAND PHARMA


Compare Fixed Capital/Sales ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹28,489.8 Cr 6.4% -4% 8.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,837.0 Cr 1% 3.8% 0.6% Stock Analytics
DIVIS LABORATORIES ₹159,175.0 Cr -1.7% -4.1% 3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,394.0 Cr -0% -3% 33.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,999.0 Cr -1.3% -1.3% 8.6% Stock Analytics
CIPLA ₹100,379.0 Cr -1.1% -6.3% -18.3% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

6.4%

-4%

8.7%

SENSEX

-0.8%

-11.7%

-3.6%


You may also like the below Video Courses